Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Bank of America Corp DE

Bank of America Corp DE decreased its holdings in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 9.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 260,954 shares of the business services provider's stock after selling 28,006 shares during the period. Bank of America Corp DE owned about 0.51% of Exponent worth $23,251,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently added to or reduced their stakes in the stock. BLI Banque de Luxembourg Investments purchased a new stake in Exponent during the 4th quarter worth approximately $12,564,000. Algert Global LLC acquired a new stake in shares of Exponent in the fourth quarter worth approximately $1,030,000. Ameriprise Financial Inc. increased its position in shares of Exponent by 7.3% during the fourth quarter. Ameriprise Financial Inc. now owns 646,026 shares of the business services provider's stock worth $57,561,000 after purchasing an additional 44,002 shares in the last quarter. AXA S.A. raised its stake in Exponent by 35.4% in the 4th quarter. AXA S.A. now owns 24,000 shares of the business services provider's stock valued at $2,138,000 after purchasing an additional 6,281 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV lifted its holdings in Exponent by 35.2% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 2,429 shares of the business services provider's stock valued at $216,000 after purchasing an additional 633 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Trading Up 0.0%

EXPO traded up $0.03 on Thursday, hitting $77.43. 203,814 shares of the company's stock were exchanged, compared to its average volume of 245,138. Exponent, Inc. has a fifty-two week low of $73.37 and a fifty-two week high of $115.75. The stock has a market cap of $3.93 billion, a price-to-earnings ratio of 36.52 and a beta of 0.95. The firm has a 50-day moving average price of $79.06 and a 200-day moving average price of $87.51.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.04. The firm had revenue of $137.44 million for the quarter, compared to the consensus estimate of $134.63 million. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The company's revenue for the quarter was up .2% on a year-over-year basis. During the same period last year, the firm posted $0.59 earnings per share. On average, equities analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Friday, June 6th. Exponent's dividend payout ratio (DPR) is 58.54%.

Insiders Place Their Bets

In related news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares of the company's stock, valued at approximately $154,674. This trade represents a 49.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Bradley A. James sold 2,694 shares of Exponent stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total value of $214,226.88. The disclosure for this sale can be found here. Corporate insiders own 2.10% of the company's stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.